Lexaria Bioscience (LEXX) Tax Provisions (2025 - 2026)

Lexaria Bioscience's (LEXX) quarterly Tax Provisions came in at $2598.0 in Q1 2026, up 45.06% quarter-over-quarter from $1791.0 in Q4 2025.

Lexaria Bioscience (LEXX) Tax Provisions (2025 - 2026) Analysis & Trends

Lexaria Bioscience has disclosed Tax Provisions across 2 years of filings, most recently posting $2598.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -11.20 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -859,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 216,000.00
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 221.50 Mn
9 Abivax 95.45 Bn 95.45 Bn - -
10 Lexaria Bioscience 7.63 Mn 2.11 Mn 20,000.00 2,598.00

Historic Data

Download Data
DateValue
Feb 28, 2026 2,598.00
Nov 30, 2025 1,791.00